"Whatever the challenges facing the current government, Chile remains a relative oasis of clean governance, stability and economic openness and has ratified Free-Trade Agreement (FTA) with the US. Nonetheless, for the research-based pharmaceutical industry, the intellectual property (IP) environment remains deficient".
Monday, 4 August 2008
Chile pharma buoyant, but IP lags behind
According to the latest Market Watch forecast, the Chilean pharmaceutical market has grown by a robust 14.8% in US dollar terms in 2008 and by 9.2% in local currency terms. The report, which is mainly upbeat, concludes on a depressing note for IP:
Ya está disponible para ser descargado el Boletín informativo del Instituto nacional de Propiedad Industrial de Chile Inapi, correspodien...
Como el tema del rescate de los mineros será recurrente durante un tiempo, bien vale la pena aclarar algunos datos especialmente relacionado...
December 2016 saw the last weeks of the year with the eagerness of some Latin American countries to start cooperating more. Therefore, futur...